title: [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
abstract: BACKGROUND
  Lung cancer continues to have a poor prognosis despite some therapeutic advances.
  
  
  BACKGROUND
  The last fifteen years has seen a dramatic increase in the incidence of lung cancer in women and an increased proportion of adenocarcinomas in both sexes. A study of overall survival as a function of gender and other prognostic factors has been established using the cohort of patients from the study KBP-2000-CPHG.
  
  
  METHODS
  KBP-2000-CPHG is an epidemiological study carried out throughout the year 2000 looking at histologically confirmed primary lung cancers managed in general hospitals. 5,667 patients have been included. The study of survival looks at 2 and 5-year outcomes. The date and cause of death are recorded for each patient. In the absence of these data the date of the last contact is noted. If this is less than 4 months the patient is considered to be alive. If more than four months have elapsed a graduated strategy for establishing vital status is pursued which involves reviewing records from various different sources. RESULTS AWAITED: A preliminary review of the data was undertaken between September 2004 and March 2005 which obtained data on 5 567 patients. The analysis of survival according to sex and other forecast prognostic factors is underway.
authors.affiliation: Service de pneumologie, Hôpital de Meaux, France. f-blanchon@ch-meaux.fr
authors.forename: F
authors.initials: F
authors.lastname: Blanchon
authors.forename: M
authors.initials: M
authors.lastname: Grivaux
authors.forename: M
authors.initials: M
authors.lastname: Zureik
authors.forename: L
authors.initials: L
authors.lastname: Marsal
authors.forename: B
authors.initials: B
authors.lastname: Asselain
authors.forename: F-X
authors.initials: FX
authors.lastname: Lebas
authors.forename: J-P
authors.initials: JP
authors.lastname: Orlando
authors.forename: F
authors.initials: F
authors.lastname: Steenhouwer
authors.forename: M
authors.initials: M
authors.lastname: Benichou-Flurin
authors.forename: D
authors.initials: D
authors.lastname: Coëtmeur
authors.forename: T
authors.initials: T
authors.lastname: Collon
authors.forename: P
authors.initials: P
authors.lastname: David
authors.forename: B
authors.initials: B
authors.lastname: Delclaux
authors.forename: J
authors.initials: J
authors.lastname: Piquet
mesh_terms: D000230:Adenocarcinoma / Q000401:mortality / Q000473:pathology; D000328:Adult; D017677:Age Distribution; D000368:Aged; D018287:Carcinoma, Large Cell / Q000401:mortality / Q000473:pathology; D002289:Carcinoma, Non-Small-Cell Lung / Q000401:mortality / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000401:mortality / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000473:pathology; D002423:Cause of Death; D015331:Cohort Studies; D005260:Female; D005500:Follow-Up Studies; D005602:France / Q000453:epidemiology; D006769:Hospitals, General / Q000706:statistics & numerical data; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality* / Q000473:pathology; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D017678:Sex Distribution; D012907:Smoking / Q000009:adverse effects / Q000453:epidemiology; D012959:Socioeconomic Factors; D016019:Survival Analysis